The ASCO 2021 meeting is coming up on June 4-8, where MGTA will discuss the initial mobilization, collection, engraftment and disease outcome data from its Phase 2 study of MGTA-145 plus plerixafor in multiple myeloma.
© 2024 Bohdan (Bo) Khomtchouk, Ph.D.
Substack is the home for great culture